These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase. Naguib M, Daoud W, el-Gammal M, Ammar A, Turkistani A, Selim M, Altamimi W, Sohaibani MO. Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048 [Abstract] [Full Text] [Related]
28. Surgeon-controlled mivacurium administration during elective caesarean section. Abdulatif M, Taylouni E. Can J Anaesth; 1995 Feb; 42(2):96-102. PubMed ID: 7720168 [Abstract] [Full Text] [Related]
29. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium. Miller DR, Bryson G, Martineau RJ, Kitts JB, Curran M, Bragg P, Watson JB, Hull K, Lindsay P. Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511 [Abstract] [Full Text] [Related]
38. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. Ostergaard D, Jensen FS, Jensen E, Skovgaard LT, Viby-Mogensen J. Acta Anaesthesiol Scand; 1992 Oct; 36(7):702-6. PubMed ID: 1441874 [Abstract] [Full Text] [Related]
39. Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery. Lien CA, Belmont MR, Wray Roth DL, Okamoto M, Abalos A, Savarese JJ. Anesthesiology; 1999 Jul; 91(1):119-26. PubMed ID: 10422936 [Abstract] [Full Text] [Related]
40. The influence of the duration of control stimulation on the onset and recovery of neuromuscular block. McCoy EP, Mirakhur RK, Connolly FM, Loan PB. Anesth Analg; 1995 Feb; 80(2):364-7. PubMed ID: 7818125 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]